Lead Pharmacologist
US Food and Drug Administration
Dr. Li Gong is a Lead Pharmacologist in the Division of Bioequivalence III in the Office of Bioequivalence at USFDA. He has 15 + years of experience conducting bioequivalence assessment of generic drug related submissions, including, but not limited to, ANDA and ANDA supplements, pre-ANDA submission meeting & product development meeting requests, CCs as well as protocols.